The Walden Group Releases 2020 Q1 Strategic Healthcare M&A Report

The Walden Group, an M&A advisory firm focused on the healthcare industry, has published its complimentary 2020 Q1 Strategic Healthcare M&A Report, available for download on its website, www.waldenmed.com.  The report includes analysis of more than 60 M&A transactions announced of closed in Q1, among several other key developments impacting the healthcare industry including:

•      The effect of the coronavirus pandemic on supply chains and public/private partnerships between government and healthcare companies;
•      Therapeutics and vaccines in the pipeline addressing COVID-19;
•      Performance of leading healthcare companies;
•      Transformational transactions over the past year, over $100m.

The Walden Group, based in New York, represents privately-owned companies seeking to divest operations or find a home within (or relationship with) an appropriate strategic or private equity firm. The firm also represents operating companies and financial sponsors seeking to make corporate acquisitions and investments in the healthcare sector. The firm takes a "full-immersion" approach, with more than 30 years of healthcare experience, deep industry knowledge, a worldwide network of close relationships and a lengthy track record of completed transactions.

The Walden Group, Inc. 

560 White Plains Rd. I Tarrytown, NY 10591

914 332 9700 / efax 914 303 5043

office@waldenmed.com

www.waldenmed.com